Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
EchoGo® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an…
Orchid Pharma Limited, (‘Orchid Pharma’) based in Chennai, India, the only Indian pharmaceutical company to have ever invented…
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…
SeQuent Scientific and Viyash Lifesciences Announce Strategic Merger to Create a Global AnimalHealth Leader with End-to-End Integrated Capabilities…
Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug, lenacapavir, accessible to…
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic…
Alkem Laboratories denies claims of Pan-D, Clavam 625 batches being not-of-standard quality The samples of both products mentioned…
Amneal Pharmaceuticals, Inc. announced that it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food…
BioMatrix Healthcare Pvt. Ltd announced that OSD facility has received EUGMP approval!This achievement is a testament to unwavering…